Related Experiment Videos
Increased expression of a novel leukocytic factor in patients with hemolytic anemia
A Larochelle1, D Marceau, E de Médicis
1Département de Biochimie, Faculté de Médecine, Université de Sherbrooke, Québec, Canada.
Abstract:
Misprimed polymerase chain reaction (PCR) products were generated from the crude leukocytic DNA extract of four of five patients with hereditary hemolytic anemia, during the course of exon 6 pyruvate kinase L gene amplification. These by-products, which originated from abundant mRNA templates, were not observed in seven healthy individuals. Two markers were cloned (GenBank accession numbers M64700 and M64701). We focused further studies on one of the human markers associated with hereditary hemolytic anemia, human DNA marker B (HUMDNAMB). HUMDNAMB is a 451-bp open reading frame that has never been described previously. The nucleic acid sequence region 303-416 is 63% homologous to a coding region of the bovine interferon alpha-A gene. Matrix analysis of the amino acid sequences reveals a structural similarity between the two proteins. The HUMDNAMB protein is expected to be larger than interferons, based on the size of its 2-kb messenger RNA detected by Northern blot in human leukocytes, fetal liver, and fetal intestine.
Insights
Researchers identified a novel human DNA marker (HUMDNAMB) associated with hereditary hemolytic anemia. This marker, distinct from healthy individuals, shows potential for diagnosing this genetic blood disorder.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Hereditary hemolytic anemia is a group of genetic disorders affecting red blood cells.
- Pyruvate kinase L gene mutations are a known cause of this condition.
- Diagnostic markers for hereditary hemolytic anemia are crucial for early detection.
Purpose of the Study:
- To identify novel genetic markers associated with hereditary hemolytic anemia.
- To characterize a newly discovered human DNA marker, HUMDNAMB.
- To investigate the potential diagnostic utility of HUMDNAMB.
Main Methods:
- Misprimed polymerase chain reaction (PCR) for gene amplification.
- DNA extraction from patient leukocytes.
- Gene cloning and sequencing (GenBank accession numbers M64700, M64701).
- Northern blot analysis for messenger RNA detection.
Main Results:
- PCR by-products, absent in healthy individuals, were observed in hereditary hemolytic anemia patients.
- A novel 451-bp open reading frame, HUMDNAMB, was identified and cloned.
- HUMDNAMB exhibits 63% nucleic acid homology to bovine interferon alpha-A.
- HUMDNAMB protein shows structural similarity to interferons and has a 2-kb mRNA in various human tissues.
Conclusions:
- HUMDNAMB is a novel genetic marker linked to hereditary hemolytic anemia.
- The distinct presence of HUMDNAMB in patients suggests its diagnostic potential.
- Further research into HUMDNAMB could lead to improved diagnostic tools for this anemia.